Viking Therapeutics, Inc. (VKTX): Shares Outstanding
114.79M
As of 2025-12-31
116.65M
As of 2026-06-30
+13.6%
3-year compound annual growth
+9.4%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 114.79M | +2.9% | 2026-02-11, Balance as of period end |
| 2024-12-31 | 111.57M | +11.4% | 2026-02-11, Balance as of period end |
| 2023-12-31 | 100.11M | +27.9% | 2025-02-26, Balance as of period end |
| 2022-12-31 | 78.26M | 0.0% | 2024-02-07, Balance as of period end |
| 2021-12-31 | 78.25M | +6.9% | 2023-02-10, Balance as of period end |
| 2020-12-31 | 73.22M | +1.1% | 2022-02-09, Balance as of period end |
| 2019-12-31 | 72.41M | +0.9% | 2021-02-17, Balance as of period end |
| 2018-12-31 | 71.74M | n/c | 2020-02-26, Balance as of period end |
| 2017-12-31 | 35.82M | +72.0% | 2019-03-13, Balance as of period end |
| 2016-12-31 | 20.82M | +115.0% | 2018-03-07, Balance as of period end |
| 2015-12-31 | 9.68M | +61.4% | 2017-03-21, Balance as of period end |
| 2014-12-31 | 6.00M | n/a | 2016-03-08, Balance as of period end |